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Abstract—The web-based Go-Smart environment is a scalable
system that allows the prediction of minimally invasive cancer
treatment. Interventional radiologists create a patient-specific
3D model by semi-automatic segmentation and registration of
pre-interventional CT (Computed Tomography) and/or MRI
(Magnetic Resonance Imaging) images in a 2D/3D browser
environment. This model is used to compare patient-specific
treatment plans and device performance via built-in simulation
tools. Go-Smart includes evaluation techniques for comparing
simulated treatment with real ablation lesions segmented from
follow-up scans. The framework is highly extensible, allowing
manufacturers and researchers to incorporate new ablation
devices, mathematical models and physical parameters.
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I. INTRODUCTION
Minimally invasive cancer treatments (MICTs) represent
a growing body of techniques for ablating cancerous tu-
mors, avoiding major surgery. These MICT modalities in-
clude, among others, radiofrequency ablation (RFA), where
percutaneous probes destroy tissue through Joule heating;
microwave ablation (MWA), where dielectric heating is used;
cryoablation, where tissue is lethally cooled; and irreversible
electroporation (IRE), where the cell membrane is destroyed
by an electric field. In a rapidly growing discipline, interven-
tional radiologists (IRs) must remain informed about available
treatments, as their MICT experience heavily influences pa-
tient outcomes [1]. Moreover, the boundaries of tissue necrosis
are difficult to predict heuristically, and so experience is well
complemented by medical simulation. In addition to single-
modality offline workflows [2], [3], a multi-modality tool is
thus required to flexibly compare a range of outcomes.
The Go-Smart1 project (http://gosmart-project.eu) seeks
to fulfill this, expanding on the RFA-specific IMPPACT2
project (http://imppact.eu) [3], [4]. A web-based platform
(http://smart-mict.eu) allows IRs to upload patient images,
1Project Go-Smart is co-funded by the 7th Framework Programme of the
European Union under Grant Agreement No: 600641.
2Project IMPPACT was co-funded by the 7 th Framework Programme of
the European Union under Grant Agreement No: 223877.
Figure 1. The 2D web-browser interface, showing image segmentation
and to plan, compare and validate treatment options (Fig.
1). Establishing a complete environment has required signifi-
cant development, encompassing image segmentation, registra-
tion, simulation, modeling and visualization, brought together
within a purpose-built scalable web architecture. Underpinning
Go-Smart is the principle that key MICTs share clinical and
modeling commonalities. By exploiting this, a generic com-
putational framework (Fig. 2) has been defined and adapted to
multiple MICT modalities. A core feature of this framework
is its extensibility; mathematical models, numerical codes,
equipment and even modalities may be added through the
interface, by independent researchers and manufacturers.
Pseudonymized validation data, for quantifying the perfor-
mance of the image manipulation and simulation components,
is provided by clinical partners, alongside a Case Report
Form (CRF) containing all patient-specific data needed for
simulation. It is intended that the environment will support
independent evaluation of equipment, training of IRs, collab-
oration on treatment planning and medical research.
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Figure 2. Go-Smart framework: i) Create project; ii) View data; iii) Segment
iv); Place virtual needles; v) Simulate; vi) Register needles; vii) Validate
II. USAGE
A. Clinicians
Initially, IRs add a new patient with basic personal details
(Fig. 2.i). Pre-interventional CT and/or MRI images may be
attached to the patient data and viewed in both 2D and 3D (Fig.
2.ii). Visible structures, such as the target organ, tumors and
vessels are segmented semi-automatically using a collection of
image analysis tools (Fig. 1; Fig. 2.iii), resulting in a patient-
specific 3D model of critical structures. Regions where trans-
arterial chemoembolization (TACE) has been applied, blocking
blood supply to a tumor, may also be segmented.
Before performing an intervention, IRs place virtual probes
in the segmented image, indicating the planned target (Fig.
2.iv). Equipment parameters and treatment protocols are input,
then a simulation is executed, which estimates the lesion to
be created (Fig. 2.v). This step normally takes 10-20 minutes,
with variation for certain protocols, equipment and modalities.
After the procedure, IRs upload intra-operative scans, which
are registered to the pre-operative images, generating ablation
probe coordinates within the original patient model. The IR
may re-run the simulation with these real, measured probe
locations (Fig. 2.vi). The physical lesion is segmented from
follow-up scans performed 1-month post-intervention, and
quantitatively compared to the prediction (Fig. 2.vii).
B. Researchers, developers and manufacturers
For each treatment modality, manufacturers provide guid-
ance for IRs, often as complex algorithms, involving heating
or cooling steps governed by time, electrical impedance and/or
reported temperature. The environment incorporates these
treatment protocols, simulating an IR or generator’s behavior.
Researchers, developers and manufacturers may use the
site’s Developer Corner to add such treatment protocols,
numerical models (e.g. an Elmer input file), or equipment. All
models, probes, power generators, organs and protocols have
parameters, modifiable through this interface, which may also
be set to prompt for case-specific clinician input.
III. IMPLEMENTATION
A. Distributed Architecture
The Go-Smart distributed design is optimized for stabil-
ity and scalability. Allowing for computationally intensive
workflow steps, processing is spread between machines. The
architecture is divided into independent, separately-reusable
components with clearly defined interfaces, as follows:
• Clients: browser; Visapp (Go-Smart 3D Support);
• Servers: web server; image processing server; segmenta-
tion/registration server; simulation server.
Microsoft ASP.NET SignalR (http://signalr.net/ ) provides reli-
able, rapid communication between services, allowing clients
to interact directly with each component. Together they build
up a resilient architecture, capable of handling substantial
parallel workloads while retaining satisfactory user experience.
The web application delivers the user interface, as well as
managing communication between all components. It supports
multiple users and scalability via a separately-hostable mi-
croservice. The database and CDM (Sec. III-F) are also hosted
here, as are patient images, 3D models and simulation results.
B. Browser Client
A standard web browser is sufficient to access Go-Smart,
providing users with roaming access to patient data. The
integrated viewer allows visual inspection of all data generated
during the workflow in a 2D, slice-based representation, with
axial, sagittal and coronal image windows. These can embed
segmented and simulated surfaces into an image (Fig. 1). Key
tools, such as image contrast windowing, provide a familiar
radiology workspace, comparable to established applications.
C. Visapp Visualization Technology
The optional client application provides seamlessly inte-
grated 3D visualization techniques, exploiting the local com-
puting power of the client PC to minimize response times. The
client’s embedded web browser replaces the deactivated fourth
view with a 3D render widget. Interaction with the underlying
web page is immediately reflected in the embedded 3D viewer
when required. The advanced 3D volume rendering techniques
employed adjust to the specifications of the local hardware.
From basic direct volume ray casting [5] to high-end global
illumination techniques [6], a variety of options are supplied
to the user. We incorporate both volumetric data and surface-
based representation of segmentation, simulation results and
MICT probes, for exploring treatment possibilities and evalu-
ation purposes, supplementing the standard 2D views.
D. Image Processing Server
This component supports the client viewer, providing image
re-slicing. All image editing tools are integrated here, such as
contrast setting, segmentation editing and needle placement.
E. Image Segmentation and Registration
Within this component, the patient-specific 3D model is
built using purpose-built tools. First, separate images are
registered into a common coordinate system using multimodal
semi-automatic registration. As well as breath-hold compen-
sation between consecutive contrast-enhanced sequences, reg-
istration of intra-operative (needle) images and post-operative
follow-up validation images to pre-operative images is also
implemented. The target organ is automatically segmented
through organ-specific tools, using a rough decomposition of
abdominal structures into semantic objects and morphology-
based segmentation. For certain organs and lesions, single-
click initialization is used for robustness, supplemented by
‘drawing’ tools for manual correction. Internal tubular struc-
tures, such as vessels, bile ducts and bronchi, are extracted by
an altering Hessian vessel model based segmentation method.
F. Clinical Domain Model (CDM)
The Clinical Domain Model, a conceptual framework, gives
separate identities to components: numerical models, equip-
ment, organs and protocols, each of which maintains a set
of parameters. Their relationships and allowed combinations
are modified through a Developer Corner web-interface. Com-
position rules enable interchangeability of individual compo-
nents.
G. Simulation Architecture (GSSA)
The simulation architecture is a self-contained frame-
work marshaled by a CDM-produced XML file. It con-
tains a fully-automated, configurable tool-chain, with vol-
umetric meshing by CGAL [7] and simulation by Elmer
(https://www.csc.fi/web/elmer). New sandboxed numerical
codes may be added to GSSA using a Docker con-
tainer (http://www.docker.com) and gluing Python module.
An OpenFOAM container (http://www.openfoam.com) and a
Python/FEniCS [8] container have been implemented, allow-
ing interface users to run their own Python-based models.
IV. MATHEMATICAL MODELS
Models used for simulating key modalities are outlined. For
rigorous discussion of the theory, we refer to [9].
A. Common Models of Thermal Modalities
1) Bioheat equation with perfusion term: Following IMP-
PACT [3], [4], and Kro¨ger et al. [10], a Pennes bioheat
equation with perfusion term is used for thermal modalities
[9], [11]. The governing volumetric equation in the tissue is,
ρc∂tT − k∇2T = Qinst +Qperf , (1)
where ρ, c, k and T are the density (kg m−3), specific heat
capacity (J kg−1 K−1), thermal conductivity (W m−1 K−1)
and temperature of tissue (K), respectively. Qinst is the heat
absorbed due to ablation (W m−3). Qperf is proportional to
deviation from 310 K, with a tissue-type dependent factor.
2) Cell death model: For hyperthermia, a three-state cell
death model is used [11], [12]. Locally, cells are divided
between three states: Alive (A), Vulnerable (V ) or Dead (D).
At each point, changes of state over time follow the rules,
A ↔ V → D, A+ V +D = 1, (2)
according to coupled evolution equations with T -dependent
coefficients. The lesion is defined as Σ := {D > 0.8}.
B. MICT-Specific Models
1) Microwave ablation: This modality is modeled by cou-
pling the above bioheat and death equations to a reduced form
of Maxwell’s equations, using a transverse-magnetic (TM)
axisymmetric cylindrical solver with temperature-dependent
electromagnetic parameters [9], [13], [14]. The field may be
used to estimate the specific absorption rate of the tissue.
2) Cryoablation: A front-capturing multi-phase solver is
applied to the Pennes equation to ensure the accuracy of
physical properties changing due to the expanding ice ball.
The effective heat capacity method is used, incorporating latent
heat of phase change into c and adjusting k. This admits a
mushy transition region between solid and liquid states [9],
[15]. The effective values are inserted into the bioheat equation
and the resulting nonlinear problem is solved iteratively.
3) Irreversible electroporation: For each step, i, in the
protocol, IRE is modeled using a simple electric potential
solver, with potential along the ith anode equal to the ith
potential difference, and zero potential along the ith cathode.
The final lesion is defined as an isovolume of the local energy
maximum over the whole protocol sequence [9], [16].
4) Radiofrequency ablation: Rather than simulating Joule
heating for each execution of this modality, an empirical
approach is used, consisting of a summation of Gaussian func-
tions centered on suitably chosen points. This was validated
during the IMPPACT project, and avoids the oversized meshes
required to capture < 1 mm diameter probe tines [4].
V. VALIDATION
The clinical partners of the project supply validation data
for the modalities described in detail above, all uploaded
and segmented by an experienced IR through the standard
interface. Validation measures include the well-established
average absolute error, α and target overlap, φS [17]. For a
simulated lesion, Σ, and segmented lesion, S, the absolute
error at a point on ∂S is the minimum distance to a point on
∂Σ. α is then the surface integral of these values divided by the
area of ∂S. φS is defined as the volumetric ratio, |S ∩Σ|/|S|.
The tool minimizes α over rigid motions of S, offsetting
post-operative registration errors. While this approach isolates
inaccuracies due to the normal clinical workflow, φS , being
independent, becomes a more useful comparative measure. To
demonstrate the process, sample cases are presented in Tab. I.
While underestimation is shown by φS  1.0, overestima-
tion, where S  Σ, is indicated by large α and φS . 1.0.
From Tab. I, it is seen that the RFA samples are particularly
well-matched, with φS > 0.7 and α < 2.5 in both cases
Table I
VALIDATION MEASURES FOR 8 CASES (3 S.F.)
Modality Cryo. IRE RFA MWA
Organ Kidney Liver Liver Liver
1. α (mm) 3.04 5.33 2.46 1.26
φS 0.953 0.357 0.701 0.593
2. α (mm) 1.95 3.28 2.01 1.41
φS 0.675 0.866 0.711 0.803
Figure 3. Validation case RFA.1 showing simulated (1) and segmented (2)
lesions, in a segmented liver (3) with tumor (4) and vessel structure (5)
(Fig. 3). RFA benefits from longstanding project experience
and well-tested empirical parameters. IRE.1, in contrast, shows
α  1 and, for IRE.2, φS  1. Often measured IRE lesions
are small, and may require fuller modeling of device settings.
Although MWA.2 is adequate, MWA.1 underestimates, with
φS < 0.6. This may be related to probe idiosyncrasies,
fundamental to MWA, and rectified through further tailored
equipment modeling. Cryo.1 is overestimated, with α  1
and φS ≈ 1, while Cryo.2 is underestimated, with φS  1.
Many treated kidney tumors are exophytic, with ablations
close to the organ wall, a limit of the simulation domain, Ω.
|Σ| is thus sensitive to needle placement error, arising from
intra-operative to pre-operative image registration. To resolve
this, Ω may be extended beyond the organ. Using Go-Smart’s
model extensibility, such changes may be made through the
web interface or back-end. As the overall validation error
has two main computational sources, image processing and
simulation, we cannot reliably distinguish their contributions.
Yet some analysis is possible. Between liver cases, the error
shown is higher for MWA and IRE than for RFA, while image
processing steps are the same, implying simulation inaccuracy.
VI. CONCLUSION
The Go-Smart web environment has been presented. It
allows IRs to simulate treatment for multiple MICT modalities
and target organs, through a web-based interface. The core
simulation codes are then validated against IR-segmented
ablation lesions. As an open-ended system, researchers and
manufacturers are able to extend the framework with addi-
tional equipment, treatment protocols and numerical models.
This framework represents a culmination of novel work
covering web infrastructure, image segmentation, image regis-
tration, theoretical modeling, visualization techniques and sim-
ulation, both extending and integrating underlying open source
solvers. Potential applications in e-health include international
collaboration on treatment planning, establishing a baseline for
MICT training and independent assessment of new equipment
and techniques against an existing body of data.
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